Related Experiment Video

Updated: Jul 5, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Nitric oxide-induced resistance or sensitization to death in tumor cells

Jean-François Jeannin1, Lissbeth Leon, Marion Cortier

  • 1EPHE, Laboratoire d'immunologie et immunothérapie des cancers, Inserm, U866, Dijon, F-21000, France. jean-francois.Jeannin@u-bourgogne.fr

Nitric Oxide : Biology and Chemistry
|May 23, 2008
PubMed

Insights

Nitric oxide (NO) can either protect tumor cells from death or make them more sensitive, depending on the context. This review explores NO

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Nitric oxide (NO) plays a complex role in cellular processes.
  • Understanding NO's impact on tumor cell death is crucial for cancer therapy.
  • Previous research indicates NO can have opposing effects on cell viability.

Purpose of the Study:

  • To review the current knowledge on nitric oxide (NO)-induced resistance or sensitization of tumor cell death.
  • To investigate the synergistic effects of NO with TNF family members, cytotoxic drugs, and ionizing radiation.
  • To discuss the molecular mechanisms underlying NO's dual role in tumor cell death.

Main Methods:

  • Literature review of studies investigating NO's effects on tumor cell death.
  • Analysis of experimental data on NO in combination with other cancer treatment modalities.
  • Discussion of molecular pathways involved in NO-mediated cell death modulation.

Main Results:

  • Nitric oxide exhibits a dual role, inducing both resistance and sensitization to tumor cell death.
  • Synergistic effects of NO were observed when combined with TNF family ligands, cytotoxic drugs, and ionizing radiation.
  • Specific molecular mechanisms contributing to NO's opposing effects have been identified.

Conclusions:

  • NO's influence on tumor cell death is context-dependent.
  • Targeting NO pathways presents potential therapeutic strategies in oncology.
  • Further research into NO's molecular mechanisms can optimize cancer treatment protocols.

More Related Videos

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...